Automation-compatible prepared culture media plate technology6 Aug 2019
Thermo Fisher Scientific's SmartPlate format brings together Oxoid and Remel prepared culture media with a durable, universal plate design, helping customers to deliver accurate results across both automated and manual methods.
The launch of a robust, easy-to-handle, sustainable plate design for prepared culture media products in the US and Canada supports the latest automated and manual methods for the analysis of microbiological samples for clinical, food safety testing and pharmaceutical laboratories.
Fully compatible with all available automated specimen processors, the SmartPlate design brings together Thermo Scientific Oxoid and Thermo Scientific Remel prepared culture media with an enhanced universal plate format for efficient and high-throughput isolation, identification, differentiation and screening of samples. The innovative SmartPlate technology offers a sustainable assay plate design that reduces the resin materials used to manufacture each plate, as well as minimizing laboratory waste thanks to its advanced durability.
Thermo Fisher Scientific is showcasing its latest SmartPlate technology during the 71st American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2019), being held August 4–8, on Booth #2110 at the Anaheim Convention Center, Anaheim, California.
"As clinical, food safety testing and pharmaceutical laboratories embrace the automation of routine analyses, scientists increasingly rely on prepared culture media plates to enable greater efficiency, while maintaining the highest levels of accuracy," said Bernd Hofmann, vice president of marketing, microbiology, Thermo Fisher Scientific. "The launch of the SmartPlate format brings together our proven Oxoid and Remel prepared culture media with a durable, universal plate design that is compatible with any specimen processor available on the market today, helping our customers deliver accurate results across both automated and manual methods."
The SmartPlate design harnesses unique stacking rings to enhance the stackability and ease-of-transport for a large number of sample plates in a single movement. This improves manual handling around the laboratory, between facilities and processing within automated-handling installations. By stacking the SmartPlate formats, laboratories can also maximize the valuable capacity of premium laboratory workspaces, including refrigerators and incubators.
Ajinomoto introduces fast track platform for drug product manufacturing
30 Jun 2020
AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic.Read more
Piramal acquires solid oral dosage drug product facility from G&W Laboratories
22 Jun 2020
The site can also produce liquids, creams, and ointments, further expanding the CDMO's portfolio.Read more
Catalent and ViralClear Pharmaceuticals partner on potential COVID-19 treatment
22 Jun 2020
The CDMO will work on developing a solution and a solid oral dosage form of ViralClear's merimepodib.Read more
Sanofi to build EUR 490 million vaccine production facility in France
16 Jun 2020
The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccinesRead more
Vektor Pharma finalizes formula for novel transdermal drug delivery system to treat Parkinson's
8 Jun 2020
Optimizing the dosage form's efficiency reduces the amount of drug required in each patch.Read more
Emergent bags $628 million "landmark" CDMO deal to produce COVID-19 vaccine candidates
2 Jun 2020
The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs.Read more
Changes needed to prevent controversial pay-for-delay pharma deals
26 May 2020
Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.Read more
SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient
26 May 2020
SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.Read more
AbCellera and Lilly seal multi-year antibody discovery collaboration
25 May 2020
AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.Read more
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment
25 May 2020
The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation